(BUSINESS WIRE)--Community pharmacists have stepped up to meet the shortage of Tamiflu by compounding doses for children suffering from the H1N1 flu virus, but they are struggling with supply problems and insurance plans, according to the National Community Pharmacists Association.
Tamiflu’s manufacturer, Roche, asked pharmacists to compound the medicine until supplies improve. The time-intensive process involves extracting powder from capsules, calculating the quantity of medicine, and mixing the right amount with liquid, such as cherry syrup, to produce a suspension with the appropriate prescribed strength for young children.
Over a recent 48-hour period, 80 community pharmacists from around the country told NCPA about their experiences compounding Tamiflu. Nearly half (48%) reported preparing 25 or more suspension compounds since Sept. 1. Virtually all (97%) experienced difficulty in obtaining commercial Tamiflu suspension and many (48%) said the same about Tamiflu capsules, consistent with a front-page story in The Washington Post.
Most prescription coverage is administered by pharmacy benefit managers (PBMs) and 61% of pharmacists surveyed had difficulty adjudicating claims with them for compounded Tamiflu. Most commonly mentioned were the big three – CVS Caremark, Express Scripts, Inc. and Medco Health Solutions, Inc. – but nearly every PBM was identified as a source of difficulty.
Experts advise starting antiviral treatment as quickly as possible. But one pharmacist said, “We had several children that are ‘covered’ by the federal employee [health benefits] program [administered by CVS Caremark] and were told that this compound requires prior authorization which can take from 24 to 72 hours to obtain.”
“Compounding has long been a specialty of independent community pharmacists, and they’re working overtime against H1N1,” said NCPA Executive Vice President and CEO Bruce T. Roberts, RPh. “They’ve helped countless children and won the gratitude of just as many parents.”
“Unfortunately, this is harder than it should be,” Roberts added. “We hope insurance plans and PBMs will reexamine their claims processes to ensure kids get relief as quickly as possible.”
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
www.artsacrossgeorgia.com
Arts Across Georgia
Showing posts with label H1N1. Show all posts
Showing posts with label H1N1. Show all posts
Tuesday, November 03, 2009
Friday, October 30, 2009
Study Examines Mercury in Vaccines
/PRNewswire/ -- The injectable, multi-dose H1N1 vaccine contains the mercury-based preservative thimerosol to reduce risks of bacterial contamination. The presence of thimerosol has once again raised concerns whether there are risks posed to children when the tiny amount of mercury contained in thimerosol is included in a vaccine. In a recent issue of the Journal of Pediatrics, however, a team of scientists supported by the National Institutes of Health reported findings that should alleviate those concerns. The researchers, led by author Michael E. Pichichero, MD, Director of the Rochester General Research Institute, Rochester General Hospital, Rochester, NY evaluated levels of mercury in the blood of the smallest children -- prematurely born and low birth weight infants after they received a dose of a childhood vaccine containing thimerosol. They found the levels of mercury were exceedingly low.
The issue of administering vaccines containing mercury has been controversial because at very high levels mercury is known to cause organ damage (brain/kidneys). Consequently in 2001, as a precaution, at the prompting of the American Academy of Pediatrics, the Centers for Disease Control, and the Food and Drug Administration, the use of thimerosol in childhood vaccines was reduced or eliminated. However, after examining the evidence the Institute of Medicine issued an opinion that an association between thimerosol exposure and autism was not supported by the evidence. Nevertheless the contention that mercury in vaccines causes autism continues to be debated. The newly released multi-dose, injectable H1N1 Influenza vaccines contain the preservative thimerosol and thimerosol is 50% ethyl mercury, which has sparked a renewed debate on the safety of administering this new influenza vaccine.
The purpose of the study was to find out how much mercury from a vaccine containing thimerosol stays in a child's body," said Dr. Pichichero. "What we found was that blood mercury levels before vaccination were often detectable, even at a level similar to many children after the vaccination. By just breathing the air, mothers were passing to their unborn infants some slight amounts of mercury. The mothers did not eat fish that contains mercury, so in the United States and other countries where fish is consumed by pregnant women the levels of mercury would be presumably even higher. After the babies were given vaccines containing thimerosol, their blood levels of mercury did rise to very low levels and then fell rapidly to baseline levels by day ten after the vaccination."
Since thimerosol has been largely removed from vaccines in the US since 2001, this study of 72 newborn infants was conducted at the Hospital Durand in Buenos Aires, Argentina. In Argentina, like many countries of the world, vaccines are purchased through sources supported by the World Health Organization and the WHO has rejected the notion that thimerosol in vaccines is unsafe. This is the third and final study by Dr. Pichichero and his colleagues that tested mercury levels following the injection of vaccines containing thimerosol. Previous studies were conducted on term newborns, and on 2-and 6-month old infants. In those studies, the researchers also found the mercury levels in the vaccinated children were very low and quickly returned to pre-vaccine levels, usually within three to seven days. In 1999, when the first concerns about thimerosol in vaccines was raised, it was presumed that the ethyl mercury in thimerosol would behave in the same manner as methyl mercury in fish after ingested. The three NIH-supported studies clearly refuted that idea.
Dr. Pichichero and colleagues concluded that with this latest data, it is time to recognize that the risk of exposure to thimerosol in vaccines is minimal to non-existent. "The H1N1 vaccine is safe and should be given to those at risk as recommended by the US Centers for Disease Control," Dr. Pichichero said.
Rochester General Research Institute is part of the Rochester General Health System (RGHS) in Rochester, NY. The Research Institute is focused on clinical and translational research in the areas of infectious diseases and immunology, cardiovascular diseases, cancer, and innovations in
biotechnology. The Rochester General Research Institute has alliances with the Rochester Institute of Technology, the Cleveland Clinic and Roswell Park Cancer Institute.
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
www.artsacrossgeorgia.com
Arts Across Georgia
The issue of administering vaccines containing mercury has been controversial because at very high levels mercury is known to cause organ damage (brain/kidneys). Consequently in 2001, as a precaution, at the prompting of the American Academy of Pediatrics, the Centers for Disease Control, and the Food and Drug Administration, the use of thimerosol in childhood vaccines was reduced or eliminated. However, after examining the evidence the Institute of Medicine issued an opinion that an association between thimerosol exposure and autism was not supported by the evidence. Nevertheless the contention that mercury in vaccines causes autism continues to be debated. The newly released multi-dose, injectable H1N1 Influenza vaccines contain the preservative thimerosol and thimerosol is 50% ethyl mercury, which has sparked a renewed debate on the safety of administering this new influenza vaccine.
The purpose of the study was to find out how much mercury from a vaccine containing thimerosol stays in a child's body," said Dr. Pichichero. "What we found was that blood mercury levels before vaccination were often detectable, even at a level similar to many children after the vaccination. By just breathing the air, mothers were passing to their unborn infants some slight amounts of mercury. The mothers did not eat fish that contains mercury, so in the United States and other countries where fish is consumed by pregnant women the levels of mercury would be presumably even higher. After the babies were given vaccines containing thimerosol, their blood levels of mercury did rise to very low levels and then fell rapidly to baseline levels by day ten after the vaccination."
Since thimerosol has been largely removed from vaccines in the US since 2001, this study of 72 newborn infants was conducted at the Hospital Durand in Buenos Aires, Argentina. In Argentina, like many countries of the world, vaccines are purchased through sources supported by the World Health Organization and the WHO has rejected the notion that thimerosol in vaccines is unsafe. This is the third and final study by Dr. Pichichero and his colleagues that tested mercury levels following the injection of vaccines containing thimerosol. Previous studies were conducted on term newborns, and on 2-and 6-month old infants. In those studies, the researchers also found the mercury levels in the vaccinated children were very low and quickly returned to pre-vaccine levels, usually within three to seven days. In 1999, when the first concerns about thimerosol in vaccines was raised, it was presumed that the ethyl mercury in thimerosol would behave in the same manner as methyl mercury in fish after ingested. The three NIH-supported studies clearly refuted that idea.
Dr. Pichichero and colleagues concluded that with this latest data, it is time to recognize that the risk of exposure to thimerosol in vaccines is minimal to non-existent. "The H1N1 vaccine is safe and should be given to those at risk as recommended by the US Centers for Disease Control," Dr. Pichichero said.
Rochester General Research Institute is part of the Rochester General Health System (RGHS) in Rochester, NY. The Research Institute is focused on clinical and translational research in the areas of infectious diseases and immunology, cardiovascular diseases, cancer, and innovations in
biotechnology. The Rochester General Research Institute has alliances with the Rochester Institute of Technology, the Cleveland Clinic and Roswell Park Cancer Institute.
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
www.artsacrossgeorgia.com
Arts Across Georgia
Thursday, September 24, 2009
Children Prescribed Tamiflu Could Get Wrong Dose
TT Note: It seems like so many parents are rushing to the doctor with children who are exhibiting flu like symptoms. Please be aware that the dosing for Tamiflu could be wrong. Be sure to double check everything with your pharmacist.
Medical and public health officials should be alerted to the serious potential for dosing errors in children prescribed Tamiflu® due to confusion when trying to follow the medication label and using the prepackaged dosing syringe, warns Emory University health literacy researcher Ruth Parker, MD, in the Sept. 23 online edition of the New England Journal of Medicine.
Parker, lead author of the special article and professor of medicine in the Emory School of Medicine, and colleagues say parents and caregivers may face difficulty calculating the correct dosage of Tamiflu® (oseltamivir) Oral Suspension to administer to their children because of misaligned instructions on the pharmacy label, the manufacturer's printed label, the accompanying Consumer Medication Information and the dosing syringe packaged with the Tamiflu®.
In the article, Parker, Kara Jacobson, MPH, of Emory's Rollins School of Public Health, and colleagues provide the example of a 6-year-old recently prescribed Tamiflu® for H1N1 influenza. While the medication bottle specified dosage in volume units (¾ of a teaspoon twice a day), the syringe prepackaged with the medication was marked in mass units (milligrams). It required a complex calculation for the parents to convert teaspoons to milligrams to determine just how much medication the child should receive.
"It is critical that immediate steps are taken to improve the prescribing instructions for this drug in children to ensure its safe use," says Parker. "We recommend that all pharmacies are instructed to ensure that the label instructions for use are in the same dosing units as those on the measurement device dispensed with Tamiflu® (oseltamivir)."
Tamiflu® is an antiviral medication prescribed to help stop the spread of the flu virus inside the body. It is typically given within a couple of days of a patient experiencing flu-like symptoms. It also can be used to prevent flu in someone who may have been exposed to the virus but is not yet displaying symptoms.
Parker says there is a need to improve instructions on medication labels beyond Tamiflu® Oral Suspension. She and colleagues suggest that all medication-measuring devices for children be changed to include volumetric dosage markings (milliliters or teaspoon). In addition, all materials (e.g. package insert, Consumer Medication Information, package label, and stick-on container label dosing instructions) should contain clear, consistent information that patients can understand and follow for safe and effective medication use.
"We view this as an issue at the intersection of patient safety and health literacy," says Parker.
In addition to Parker and Jacobson, study authors were: Michael S. Wolf, PhD, MPH, of the Feinberg School of Medicine, Northwestern University; and Alastair J.J. Wood, MD, of Symphony Capital LLC and Weil Cornell School of Medicine.
The article, "Serious Risk of Confusion in Dosing Tamiflu Oral Suspension in Children," published online Sept. 23 by the New England Journal of Medicine, can be viewed at www.nejm.org and h1n1.nejm.org. It will be published in print at a later date.
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
Medical and public health officials should be alerted to the serious potential for dosing errors in children prescribed Tamiflu® due to confusion when trying to follow the medication label and using the prepackaged dosing syringe, warns Emory University health literacy researcher Ruth Parker, MD, in the Sept. 23 online edition of the New England Journal of Medicine.
Parker, lead author of the special article and professor of medicine in the Emory School of Medicine, and colleagues say parents and caregivers may face difficulty calculating the correct dosage of Tamiflu® (oseltamivir) Oral Suspension to administer to their children because of misaligned instructions on the pharmacy label, the manufacturer's printed label, the accompanying Consumer Medication Information and the dosing syringe packaged with the Tamiflu®.
In the article, Parker, Kara Jacobson, MPH, of Emory's Rollins School of Public Health, and colleagues provide the example of a 6-year-old recently prescribed Tamiflu® for H1N1 influenza. While the medication bottle specified dosage in volume units (¾ of a teaspoon twice a day), the syringe prepackaged with the medication was marked in mass units (milligrams). It required a complex calculation for the parents to convert teaspoons to milligrams to determine just how much medication the child should receive.
"It is critical that immediate steps are taken to improve the prescribing instructions for this drug in children to ensure its safe use," says Parker. "We recommend that all pharmacies are instructed to ensure that the label instructions for use are in the same dosing units as those on the measurement device dispensed with Tamiflu® (oseltamivir)."
Tamiflu® is an antiviral medication prescribed to help stop the spread of the flu virus inside the body. It is typically given within a couple of days of a patient experiencing flu-like symptoms. It also can be used to prevent flu in someone who may have been exposed to the virus but is not yet displaying symptoms.
Parker says there is a need to improve instructions on medication labels beyond Tamiflu® Oral Suspension. She and colleagues suggest that all medication-measuring devices for children be changed to include volumetric dosage markings (milliliters or teaspoon). In addition, all materials (e.g. package insert, Consumer Medication Information, package label, and stick-on container label dosing instructions) should contain clear, consistent information that patients can understand and follow for safe and effective medication use.
"We view this as an issue at the intersection of patient safety and health literacy," says Parker.
In addition to Parker and Jacobson, study authors were: Michael S. Wolf, PhD, MPH, of the Feinberg School of Medicine, Northwestern University; and Alastair J.J. Wood, MD, of Symphony Capital LLC and Weil Cornell School of Medicine.
The article, "Serious Risk of Confusion in Dosing Tamiflu Oral Suspension in Children," published online Sept. 23 by the New England Journal of Medicine, can be viewed at www.nejm.org and h1n1.nejm.org. It will be published in print at a later date.
-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
Thursday, May 21, 2009
H1 N.......what?!!? America's Mexican "Influenza"? asks Researcher Lawrence Broxmeyer, MD
TT Note: Hold on to your flu-like symptoms, folks. This doctor looks at the flu epidemic of 1918 and some researchers' findings. When compared to today's trendy virus, there appears to be some room for debate on the current flu-like symptoms. Is it really the flu?
/24-7 / -- All that is H1N1 does not glitter, at least with respect to the tireless efforts of Virologists, Epidemiologists and Health Officials to stake claim that the current "flu-like illness" pandemic is tied to "Influenza".
"The "H" and "N" of influenza sub-typing" Lawrence Broxmeyer, MD mentions, "revolves around two glycoproteins called Hemagglutin and Neuraminidase, both of which can be, and are, associated with infectious diseases such as the minuscule, viral forms of tuberculosis, a disease which ought to be high on the differential diagnosis for 'flu-like illness' . Since August, 2008, a Medline study in the Journal of Clinical Biochemistry showed that sputum neuraminidase levels over 1.0 mU per mL were proven associated with having tuberculosis in 92% of cases, previous to which bacteria closely related to TB where shown, through crystallization, to produce the same protein neuraminidase used to subtype 'Influenza'."
Furthermore, reminded Lawrence Broxmeyer MD, "Khomenko's 1993 study, showed that the explosive contagiousness of just such influenza-like forms of tuberculosis are exactly the stuff that previous epidemics and pandemics could have been made of." Khomenko was cited by Nobel nominee Lida Mattman in her textbook prior to her untimely death last year.
"That is exactly why", reiterated Lawrence Broxmeyer, MD "that in response to the present world "flu" pandemic, Japan's Health Ministry's Tuberculosis Infection Diseases Control Division deputy director Takeshi Enami went hand in hand with Yoshio Nanba, director of The Office of Pandemic Influenza Preparedness and Response, to attend a news conference in Tokyo on May 1, 2009."
But back in the US, the CDC and NIH seem to feel differently, ignoring everything but "the virus". There was much the same "Influenza" talk when in 1990, a new multi-drug-resistant (MDR) tuberculosis outbreak took place in a large Miami municipal hospital. Soon thereafter, similar outbreaks in three New York City hospitals left many sufferers dying within weeks. By 1992, approximately two years later, drug-resistant tuberculosis had spread to seventeen US states, with mini-epidemics in Florida, Michigan, New York, California, Texas, Massachusetts, and Pennsylvania and was reported, not by the American, but the international media, as out of control. Viral forms of swine, avian and human TB can be transmitted from one species to another. By 1993 the World Health Organization (WHO), proclaimed tuberculosis a global health emergency.
"No one can deny the similarities between the onset of the 1918 epidemic and that of today," mentioned Lawrence Broxmeyer MD, "Yet a Press Release, issued on August 19, 2008, by the National Institute of Allergy and Infectious Diseases (NIAID), contains a striking finding and conclusion: The 20 to 40 million deaths worldwide from the great 1918 Influenza ("Flu") Pandemic were NOT due to "flu" or a virus, but to pneumonia caused by massive bacterial infection."
Subsequently, a study published in JAMA by Talbot and Moore in 2000 showed that Mexican immigrants to the US have the highest case rates for tuberculosis among foreign born persons.
The research of Lawrence Broxmeyer MD first proclaimed that the 1918 pandemic was due to bacteria, particularly mutant forms of flu-like fowl, swine, bovine, and human tuberculosis (TB) bacteria. These forms of tuberculosis are often viral-like, mutate frequently and can "skip" from one species to another. Moreover the antibodies from such viral TB forms react in the compliment fixation and later "viral" assays. They also grow on cultures which are supposed to grow only viruses.
In a supportive 16-page-paper which appeared in Population and Development Review, University of California demographers Andrew Noymer and Michel Garenne came up with convincing statistics showing that undetected tuberculosis may have been the real killer in the 1918 flu epidemic.
Noymer's hypothesis stands sound against history. Few flu "experts" are aware that in medical texts printed circa 1918 "Influenza" was attributed not to a virus but a bacteria called Mycobacterium influenzae, discovered by Pfeiffer and Canon in 1892......not exactly a coincidence since Richard Pfeiffer worked, at one time, for Robert Koch, the discoverer of tuberculosis, a disease also caused by another bacillus called Mycobacterium tuberculosis. Both mycobacteria stained best with carbol-fuchsin, a bacterial stain commonly used in the staining of mycobacteria as it has an affinity for the mycolic acids found in their cell walls. Mycobacteria such as tuberculosis are particularly deadly because they share properties of the fungi ("myco-") as well as bacteria. TB was, not all that long ago, referred to as "captain of the men of death".
Mycobacterium influenzae was considered by most to be the cause of influenza until 1933. But there were serious diagnostic problems with Mycobacterium influenza. Stengel and Fox warned about them in their widely quoted W.B. Saunder's 1915 version of "A Textbook of Pathology". Problems with identification revolved mainly in that although the bacterial influenza occurred abundantly in the sputum of flu patients at first, it decreased in quantity as the cases advanced. And when purulent expectoration stopped Mycobacterium influenzae "disappears entirely".
In 1933 English physicians Wilson Smith, Christopher H. Andrewes, and Patrick P. Laidlaw removed secretions from the throat of a humans with flu-like symptoms thought to have "influenza" , and then filtered out a suspected infectious agent, which by virtue of the fact that it went through a filter was falsely proclaimed to be "a virus". Injecting it into ferrets, the ferrets then developed the same flu-like symptoms which Smith, Andrews and Laidlaw summarily declared as "influenza".
But to government pathologist and pioneer physician/researcher Sir John Crofton (1912-69 ), who by virtue of his office had examined some of Laidlaw's human "Flu" samples, Laidlaw's entire study was flawed. Crofton found Laidlaw's Flu samples to be laced with Mycobacteria influenza, which by then had been renamed Hemophyllis Influenza. Crofton personally confronted and challenged Laidlaw to come to his laboratory for the proof that his Influenza samples weren't viral. However historical and political momentum carried Laidlaw's study through and a great opportunity was missed to correct the record.
In a landmark study, Dr. Robert Donaldson, working out of the Pathological Society of Great Britain had ruled out that the mycobacteria now referred to as H. Influenza by itself was behind 1918, perhaps because of its disappearing nature. Yet at the same time he quickly added that there wasn't "the slightest shred of evidence" that the disease was due to a "virus" or influenza. Nor was Donaldson ever able to refute Broxmeyer and Noymer's feelings that TB was behind the many deaths in the pandemic, specifically because it is well known that secondary bacterial infections, be they from opportunistic Haemophillus influenza or any other common bacteria, are a common secondary manifestation in TB-infected lungs. During the pandemic, one-third of patients who had Haemophillus influenza where also found to have tuberculosis - keeping in mind, as always, that many other cases with TB went undiagnosed.
"In order to understand why we have this emphasis by those virologists invested in a 'killer flu' in the US today", said Lawrence Broxmeyer MD, "one must look back historically at the science itself."
In truth, until the late 1940s influenza 'viruses' were studied as infections, which, although filterable, were conceived of as analogous to bacteria, a kind of ultra or viral-like bacteria.
Not to be deterred, and still seeing Influenza as a great opportunity for virology, in 1941 virologist Hirst claimed that influenza ''virus'' could agglutinate (or clot) red blood cells of fowl and other animal species. The "H" in H1N1 comes to us through Hirst, who showed that ''virus'' particles first adsorbed to the red cells and, after a certain time, eluted again as a result of what could be interpreted as an enzymatic reaction. But 6 years later, Middlebrook and Dubos made this seem nothing more than a cheap hat trick by showing that similarly red blood cell agglutination could be produced by sera from patients with tuberculosis. Takahashi and Ono reviewed similar red cell agglutination occurring in the presence of tuberculous serums.
"As Influenza historian van Helvoort aptly pointed out", summed-up Lawrence Broxmeyer MD, "indeed, in the 1930s and 1940s the concept of 'filterable viruses', including Influenza, were subject to such criticism that Virology's very foundations were threatened. Dogmatized statements like those coming from pioneer virologist Andre Lwoff in 1957 : ''Viruses should be considered as viruses because viruses are viruses'' were totally unacceptable, and did little to help the situation.
So it was in 1952 that Cornelius P. Rhoads, Director of Sloan-Kettering Institute for Cancer Research in New York City, remarked in a conference introduction that the term ''viruses'', such as that of Influenza, had achieved ''a high professional status with doubtful credentials''.
What we have today, mentioned Broxmeyer, is a pandemic with "flu-like" symptoms. And flu-like symptoms dosen't necessarily mean Influenza is the underlying cause.
Reference: Pubmed. Lawrence Broxmeyer MD, Bird flu, influenza and 1918: The case for mutant Avian tuberculosis. Med Hypotheses. 2006;67(5):1006-15. Epub 2006 Jun 27. http://drbroxmeyer.netfirms.com/PDF%20001%20Bird%20Flu%20Editorial.pdf
-----
www.fayettefrontpage.com
Fayette Front Page
Fayetteville, Peachtree City, Tyrone
www.georgiafrontpage.com
Georgia Front Page
www.politicalpotluck.com
Political News You Can Use
/24-7 / -- All that is H1N1 does not glitter, at least with respect to the tireless efforts of Virologists, Epidemiologists and Health Officials to stake claim that the current "flu-like illness" pandemic is tied to "Influenza".
"The "H" and "N" of influenza sub-typing" Lawrence Broxmeyer, MD mentions, "revolves around two glycoproteins called Hemagglutin and Neuraminidase, both of which can be, and are, associated with infectious diseases such as the minuscule, viral forms of tuberculosis, a disease which ought to be high on the differential diagnosis for 'flu-like illness' . Since August, 2008, a Medline study in the Journal of Clinical Biochemistry showed that sputum neuraminidase levels over 1.0 mU per mL were proven associated with having tuberculosis in 92% of cases, previous to which bacteria closely related to TB where shown, through crystallization, to produce the same protein neuraminidase used to subtype 'Influenza'."
Furthermore, reminded Lawrence Broxmeyer MD, "Khomenko's 1993 study, showed that the explosive contagiousness of just such influenza-like forms of tuberculosis are exactly the stuff that previous epidemics and pandemics could have been made of." Khomenko was cited by Nobel nominee Lida Mattman in her textbook prior to her untimely death last year.
"That is exactly why", reiterated Lawrence Broxmeyer, MD "that in response to the present world "flu" pandemic, Japan's Health Ministry's Tuberculosis Infection Diseases Control Division deputy director Takeshi Enami went hand in hand with Yoshio Nanba, director of The Office of Pandemic Influenza Preparedness and Response, to attend a news conference in Tokyo on May 1, 2009."
But back in the US, the CDC and NIH seem to feel differently, ignoring everything but "the virus". There was much the same "Influenza" talk when in 1990, a new multi-drug-resistant (MDR) tuberculosis outbreak took place in a large Miami municipal hospital. Soon thereafter, similar outbreaks in three New York City hospitals left many sufferers dying within weeks. By 1992, approximately two years later, drug-resistant tuberculosis had spread to seventeen US states, with mini-epidemics in Florida, Michigan, New York, California, Texas, Massachusetts, and Pennsylvania and was reported, not by the American, but the international media, as out of control. Viral forms of swine, avian and human TB can be transmitted from one species to another. By 1993 the World Health Organization (WHO), proclaimed tuberculosis a global health emergency.
"No one can deny the similarities between the onset of the 1918 epidemic and that of today," mentioned Lawrence Broxmeyer MD, "Yet a Press Release, issued on August 19, 2008, by the National Institute of Allergy and Infectious Diseases (NIAID), contains a striking finding and conclusion: The 20 to 40 million deaths worldwide from the great 1918 Influenza ("Flu") Pandemic were NOT due to "flu" or a virus, but to pneumonia caused by massive bacterial infection."
Subsequently, a study published in JAMA by Talbot and Moore in 2000 showed that Mexican immigrants to the US have the highest case rates for tuberculosis among foreign born persons.
The research of Lawrence Broxmeyer MD first proclaimed that the 1918 pandemic was due to bacteria, particularly mutant forms of flu-like fowl, swine, bovine, and human tuberculosis (TB) bacteria. These forms of tuberculosis are often viral-like, mutate frequently and can "skip" from one species to another. Moreover the antibodies from such viral TB forms react in the compliment fixation and later "viral" assays. They also grow on cultures which are supposed to grow only viruses.
In a supportive 16-page-paper which appeared in Population and Development Review, University of California demographers Andrew Noymer and Michel Garenne came up with convincing statistics showing that undetected tuberculosis may have been the real killer in the 1918 flu epidemic.
Noymer's hypothesis stands sound against history. Few flu "experts" are aware that in medical texts printed circa 1918 "Influenza" was attributed not to a virus but a bacteria called Mycobacterium influenzae, discovered by Pfeiffer and Canon in 1892......not exactly a coincidence since Richard Pfeiffer worked, at one time, for Robert Koch, the discoverer of tuberculosis, a disease also caused by another bacillus called Mycobacterium tuberculosis. Both mycobacteria stained best with carbol-fuchsin, a bacterial stain commonly used in the staining of mycobacteria as it has an affinity for the mycolic acids found in their cell walls. Mycobacteria such as tuberculosis are particularly deadly because they share properties of the fungi ("myco-") as well as bacteria. TB was, not all that long ago, referred to as "captain of the men of death".
Mycobacterium influenzae was considered by most to be the cause of influenza until 1933. But there were serious diagnostic problems with Mycobacterium influenza. Stengel and Fox warned about them in their widely quoted W.B. Saunder's 1915 version of "A Textbook of Pathology". Problems with identification revolved mainly in that although the bacterial influenza occurred abundantly in the sputum of flu patients at first, it decreased in quantity as the cases advanced. And when purulent expectoration stopped Mycobacterium influenzae "disappears entirely".
In 1933 English physicians Wilson Smith, Christopher H. Andrewes, and Patrick P. Laidlaw removed secretions from the throat of a humans with flu-like symptoms thought to have "influenza" , and then filtered out a suspected infectious agent, which by virtue of the fact that it went through a filter was falsely proclaimed to be "a virus". Injecting it into ferrets, the ferrets then developed the same flu-like symptoms which Smith, Andrews and Laidlaw summarily declared as "influenza".
But to government pathologist and pioneer physician/researcher Sir John Crofton (1912-69 ), who by virtue of his office had examined some of Laidlaw's human "Flu" samples, Laidlaw's entire study was flawed. Crofton found Laidlaw's Flu samples to be laced with Mycobacteria influenza, which by then had been renamed Hemophyllis Influenza. Crofton personally confronted and challenged Laidlaw to come to his laboratory for the proof that his Influenza samples weren't viral. However historical and political momentum carried Laidlaw's study through and a great opportunity was missed to correct the record.
In a landmark study, Dr. Robert Donaldson, working out of the Pathological Society of Great Britain had ruled out that the mycobacteria now referred to as H. Influenza by itself was behind 1918, perhaps because of its disappearing nature. Yet at the same time he quickly added that there wasn't "the slightest shred of evidence" that the disease was due to a "virus" or influenza. Nor was Donaldson ever able to refute Broxmeyer and Noymer's feelings that TB was behind the many deaths in the pandemic, specifically because it is well known that secondary bacterial infections, be they from opportunistic Haemophillus influenza or any other common bacteria, are a common secondary manifestation in TB-infected lungs. During the pandemic, one-third of patients who had Haemophillus influenza where also found to have tuberculosis - keeping in mind, as always, that many other cases with TB went undiagnosed.
"In order to understand why we have this emphasis by those virologists invested in a 'killer flu' in the US today", said Lawrence Broxmeyer MD, "one must look back historically at the science itself."
In truth, until the late 1940s influenza 'viruses' were studied as infections, which, although filterable, were conceived of as analogous to bacteria, a kind of ultra or viral-like bacteria.
Not to be deterred, and still seeing Influenza as a great opportunity for virology, in 1941 virologist Hirst claimed that influenza ''virus'' could agglutinate (or clot) red blood cells of fowl and other animal species. The "H" in H1N1 comes to us through Hirst, who showed that ''virus'' particles first adsorbed to the red cells and, after a certain time, eluted again as a result of what could be interpreted as an enzymatic reaction. But 6 years later, Middlebrook and Dubos made this seem nothing more than a cheap hat trick by showing that similarly red blood cell agglutination could be produced by sera from patients with tuberculosis. Takahashi and Ono reviewed similar red cell agglutination occurring in the presence of tuberculous serums.
"As Influenza historian van Helvoort aptly pointed out", summed-up Lawrence Broxmeyer MD, "indeed, in the 1930s and 1940s the concept of 'filterable viruses', including Influenza, were subject to such criticism that Virology's very foundations were threatened. Dogmatized statements like those coming from pioneer virologist Andre Lwoff in 1957 : ''Viruses should be considered as viruses because viruses are viruses'' were totally unacceptable, and did little to help the situation.
So it was in 1952 that Cornelius P. Rhoads, Director of Sloan-Kettering Institute for Cancer Research in New York City, remarked in a conference introduction that the term ''viruses'', such as that of Influenza, had achieved ''a high professional status with doubtful credentials''.
What we have today, mentioned Broxmeyer, is a pandemic with "flu-like" symptoms. And flu-like symptoms dosen't necessarily mean Influenza is the underlying cause.
Reference: Pubmed. Lawrence Broxmeyer MD, Bird flu, influenza and 1918: The case for mutant Avian tuberculosis. Med Hypotheses. 2006;67(5):1006-15. Epub 2006 Jun 27. http://drbroxmeyer.netfirms.com/PDF%20001%20Bird%20Flu%20Editorial.pdf
-----
www.fayettefrontpage.com
Fayette Front Page
Fayetteville, Peachtree City, Tyrone
www.georgiafrontpage.com
Georgia Front Page
www.politicalpotluck.com
Political News You Can Use
Subscribe to:
Posts (Atom)
